The Oncogenic TLS-ERG Fusion Protein Exerts Different Effects in Hematopoietic Cells and Fibroblasts

REFERENCES

• Arvand, A., H. Bastians, S. M. Welford, A. D. Thompson, J. V. Ruderman, and C. T. Denny. 1998. EWS/FLI1 up regulates mE2-C, a cyclin-selective ubiquitin conjugating enzyme involved in cyclin B destruction. Oncogene 17:2039–2045.
   PubMed Web of Science ®Google Scholar
• Bastian, L. S., M. Yagi, C. Chan, and G. J. Roth. 1996. Analysis of the megakaryocyte glycoprotein IX promoter identifies positive and negative regulatory domains and functional GATA and Ets sites. J. Biol. Chem. 271:18554–18560.
   PubMedGoogle Scholar
• Bertolotti, A., Y. Lutz, D. J. Heard, P. Chambon, and L. Tora. 1996. hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro- oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO J. 15:5022–5031.
   PubMed Web of Science ®Google Scholar
• Blackburn, M. L., H. A. Chansky, A. Zielinska-Kwiatkowska, Y. Matsui, and L. Yang. 2003. Genomic structure and expression of the mouse ESET gene encoding an ERG-associated histone methyltransferase with a SET domain. Biochim. Biophys. Acta 1629:8–14.
   PubMed Web of Science ®Google Scholar
• Caceres, J. F., S. Stamm, D. M. Helfman, and A. R. Krainer. 1994. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265:1706–1709.
   PubMed Web of Science ®Google Scholar
• Chansky, H. A., F. Barahmand-Pour, Q. Mei, W. Kahn-Farooqi, A. Zielinska-Kwiatkowska, M. Blackburn, K. Chansky, E. U. Conrad III, J. D. Bruckner, T. K. Greenlee, and L. Yang. 2004. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro. J. Orthop. Res. 22:910–917.
   PubMed Web of Science ®Google Scholar
• Chansky, H. A., M. Blackburn, W. Kahn-Farooqi, D. Benedetti, and L. Yang. 2004. Trans. 50th Annu. Meet. Orthop. Res. Soc., vol. 29, p. 0058.
   Google Scholar
• Chansky, H. A., M. Hu, D. D. Hickstein, and L. Yang. 2001. Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. Cancer Res. 61:3586–3590.
   PubMedGoogle Scholar
• Crozat, A., P. Aman, N. Mandahl, and D. Ron. 1993. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 363:640–644.
   PubMed Web of Science ®Google Scholar
• Dauphinot, L., C. De Oliveira, T. Melot, N. Sevenet, V. Thomas, B. E. Weissman, and O. Delattre. 2001. Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression. Oncogene 20:3258–3265.
   PubMed Web of Science ®Google Scholar
• Delattre, O., J. Zucman, B. Plougastel, C. Desmaze, T. Melot, M. Peter, H. Kovar, I. Joubert, P. de Jong, G. Rouleau, et al. 1992. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359:162–165.
   PubMed Web of Science ®Google Scholar
• Deneen, B., H. Hamidi, and C. T. Denny. 2003. Functional analysis of the EWS/ETS target gene uridine phosphorylase. Cancer Res. 63:4268–4274.
   PubMedGoogle Scholar
• Deneen, B., S. M. Welford, T. Ho, F. Hernandez, I. Kurland, and C. T. Denny. 2003. PIM3 proto-oncogene kinase is a common transcriptional target of divergent EWS/ETS oncoproteins. Mol. Cell. Biol. 23:3897–3908.
   PubMed Web of Science ®Google Scholar
• Eguchi, M., M. Eguchi-Ishimae, A. Tojo, K. Morishita, K. Suzuki, Y. Sato, S. Kudoh, K. Tanaka, M. Setoyama, F. Nagamura, S. Asano, and N. Kamada. 1999. Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25). Blood 93:1355–1363.
   PubMed Web of Science ®Google Scholar
• Fuchs, B., C. Y. Inwards, and R. Janknecht. 2004. Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing's sarcoma. Clin. Cancer Res. 10:1344–1353.
   PubMed Web of Science ®Google Scholar
• Ge, H., Y. Si, and A. P. Wolffe. 1998. A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF2. Mol. Cell 2:751–759.
   PubMedGoogle Scholar
• Hallier, M., A. Lerga, S. Barnache, A. Tavitian, and F. Moreau-Gachelin. 1998. The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS. J. Biol. Chem. 273:4838–4842.
   PubMed Web of Science ®Google Scholar
• Ichikawa, H., K. Shimizu, Y. Hayashi, and M. Ohki. 1994. An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res. 54:2865–2868.
   PubMed Web of Science ®Google Scholar
• Ichikawa, H., K. Shimizu, R. Katsu, and M. Ohki. 1999. Dual transforming activities of the FUS (TLS)-ERG leukemia fusion protein conferred by two N-terminal domains of FUS (TLS). Mol. Cell. Biol. 19:7639–7650.
   PubMedGoogle Scholar
• Jaishankar, S., J. Zhang, M. F. Roussel, and S. J. Baker. 1999. Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity. Oncogene 18:5592–5597.
   PubMedGoogle Scholar
• Knezevich, S. R., D. E. McFadden, W. Tao, J. F. Lim, and P. H. Sorensen. 1998. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma. Nat. Genet. 18:184–187.
   PubMed Web of Science ®Google Scholar
• Knoop, L. L., and S. J. Baker. 2001. EWS/FLI alters 5′-splice site selection. J. Biol. Chem. 276:22317–22322.
   PubMedGoogle Scholar
• Ku, D. H., C. D. Chang, J. Koniecki, L. A. Cannizzaro, L. Boghosian-Sell, H. Alder, and R. Baserga. 1991. A new growth-regulated complementary DNA with the sequence of a putative trans-activating factor. Cell Growth Differ. 2:179–186.
   PubMedGoogle Scholar
• Ladanyi, M., and J. A. Bridge. 2000. Contribution of molecular genetic data to the classification of sarcomas. Hum. Pathol. 31:532–538.
   PubMed Web of Science ®Google Scholar
• Lessnick, S. L., C. S. Dacwag, and T. R. Golub. 2002. The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell 1:393–401.
   PubMed Web of Science ®Google Scholar
• Lopez, J. A. 1994. The platelet glycoprotein Ib-IX complex. Blood Coagul. Fibrinolysis 5:97–119.
   PubMed Web of Science ®Google Scholar
• Matsui, Y., H. A. Chansky, F. Barahmand-Pour, A. Zielinska-Kwiatkowska, N. Tsumaki, A. Myoui, H. Yoshikawa, L. Yang, and D. R. Eyre. 2003. COL11A2 collagen gene transcription is differentially regulated by EWS/ERG sarcoma fusion protein and wild-type ERG. J. Biol. Chem. 278:11369–11375.
   PubMed Web of Science ®Google Scholar
• Pereira, D. S., C. Dorrell, C. Y. Ito, O. I. Gan, B. Murdoch, V. N. Rao, J. P. Zou, E. S. Reddy, and J. E. Dick. 1998. Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells. Proc. Natl. Acad. Sci. USA 95:8239–8244.
   PubMed Web of Science ®Google Scholar
• Perrotti, D., S. Bonatti, R. Trotta, R. Martinez, T. Skorski, P. Salomoni, E. Grassilli, R. V. Lozzo, D. R. Cooper, and B. Calabretta. 1998. TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis. EMBO J. 17:4442–4455.
   PubMed Web of Science ®Google Scholar
• Perrotti, D., A. Iervolino, V. Cesi, M. Cirinna, S. Lombardini, E. Grassilli, S. Bonatti, P. P. Claudio, and B. Calabretta. 2000. BCR-ABL prevents c-jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase CbetaII-dependent pathway. Mol. Cell. Biol. 20:6159–6169.
   PubMed Web of Science ®Google Scholar
• Prasad, D. D., M. Ouchida, L. Lee, V. N. Rao, and E. S. Reddy. 1994. TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain. Oncogene 9:3717–3729.
   PubMedGoogle Scholar
• Prieur, A., F. Tirode, P. Cohen, and O. Delattre. 2004. EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol. Cell. Biol. 24:7275–7283.
   PubMed Web of Science ®Google Scholar
• Rabbitts, T. H., A. Forster, R. Larson, and P. Nathan. 1993. Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat. Genet. 4:175–180.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan, R., Y. Fujimura, J. P. Zou, F. Liu, L. Lee, V. N. Rao, and E. S. Reddy. 2004. Role of protein-protein interactions in the antiapoptotic function of EWS-Fli-1. Oncogene 23:7087–7094.
   PubMed Web of Science ®Google Scholar
• Rossow, K. L., and R. Janknecht. 2001. The Ewing's sarcoma gene product functions as a transcriptional activator. Cancer Res. 61:2690–2695.
   PubMed Web of Science ®Google Scholar
• Shing, D. C., D. J. McMullan, P. Roberts, K. Smith, S. F. Chin, J. Nicholson, R. M. Tillman, P. Ramani, C. Cullinane, and N. Coleman. 2003. FUS/ERG gene fusions in Ewing's tumors. Cancer Res. 63:4568–4576.
   PubMed Web of Science ®Google Scholar
• Staege, M. S., C. Hutter, I. Neumann, S. Foja, U. E. Hattenhorst, G. Hansen, D. Afar, and S. E. Burdach. 2004. DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Cancer Res. 64:8213–8221.
   PubMed Web of Science ®Google Scholar
• Tognon, C., S. R. Knezevich, D. Huntsman, C. D. Roskelley, N. Melnyk, J. A. Mathers, L. Becker, F. Carneiro, N. MacPherson, D. Horsman, C. Poremba, and P. H. Sorensen. 2002. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell 2:367–376.
   PubMed Web of Science ®Google Scholar
• Wang, J., and J. L. Manley. 1995. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways. RNA 1:335–346.
   PubMed Web of Science ®Google Scholar
• Welford, S. M., S. P. Hebert, B. Deneen, A. Arvand, and C. T. Denny. 2001. DNA binding domain-independent pathways are involved in EWS/FLI1-mediated oncogenesis. J. Biol. Chem. 276:41977–41984.
   PubMedGoogle Scholar
• Yamamoto, K., H. Hamaguchi, K. Nagata, M. Kobayashi, F. Tanimoto, and M. Taniwaki. 1997. Establishment of a novel human acute myeloblastic leukemia cell line (YNH-1) with t(16;21), t(1;16) and 12q13 translocations. Leukemia 11:599–608.
   PubMedGoogle Scholar
• Yang, L., L. J. Embree, and D. D. Hickstein. 2000. TLS-ERG leukemia fusion protein inhibits RNA splicing mediated by serine-arginine proteins. Mol. Cell. Biol. 20:3345–3354.
   PubMedGoogle Scholar
• Yang, L., L. J. Embree, S. Tsai, and D. D. Hickstein. 1998. Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J. Biol. Chem. 273:27761–27764.
   PubMed Web of Science ®Google Scholar
• Zwerner, J. P., J. Guimbellot, and W. A. May. 2003. EWS/FLI function varies in different cellular backgrounds. Exp. Cell Res. 290:414–419.
   PubMed Web of Science ®Google Scholar